Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 7Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 7OTHER 1

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Gastrointestinal 6Other solid neoplasm 1

Conditions

Colorectal Neoplasms 6Solid Tumor Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × INDUSTRY × tipiracil × Clear all
NCT07492173 2026-03-25

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Shandong New Time Pharmaceutical Co., LTD

Phase NA Completed
76 enrolled
Other solid neoplasm

Solid Tumor Cancer

NCT04776148 2026-02-05

MK-7902-017

Merck Sharp & Dohme LLC

Phase 3 Completed
563 enrolled 32 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT05839951 2025-11-12

STAR-T

Bayer

Completed
818 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT03665506 2024-12-03

TACTIC

Servier

Completed
315 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02743221 2024-08-20

TASCO1

Servier

Phase 2 Completed
154 enrolled 15 charts
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03974594 2022-04-19

Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Completed
64 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02613221 2019-07-31

APOLLON

Takeda

Phase 1/2 Completed
56 enrolled 26 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡